"Sodium tetradecyl sulfate"

Low concentration of sodium tetradecyl sulfate and hypertonic glucose solution for the treatment of telangiectasia: A prospective randomized clinical trial. This study aimed to compare telangiectasias disappearance after sclerotherapy with hypertonic glucose (HG) and different concentrations of sodium tetradecyl sulfate (STS). Women aged 18-70 years with telangiectasias were included

Sclerotherapy of telangiectasias: A prospective, randomized, comparative clinical trial of hypertonic glucose versus sodium tetradecyl sulfate. To compare the disappearance of the telangiectasias after sclerotherapy with 75% glucose (HG) versus 0.2% sodium tetradecyl sulfate (STS). This prospective, randomized clinical trial compared the results of sclerotherapy of the telangiectasias with HG

Sodium Tetradecyl Sulfate An official website of the United States government Here's how you know Log inAccess keysNCBI HomepageMyNCBI HomepageMain ContentMain NavigationBookshelfSearch databaseBooksAll DatabasesAssemblyBiocollectionsBioProjectBioSampleBooksClinVarConserved DomainsdbGaPdbVarGeneGenomeGEO DataSetsGEO ProfilesGTRHomoloGeneIdentical Protein GroupsMedGenMeSHNLM during LactationNo information is available on the clinical use of sodium tetradecyl sulfate during breastfeeding. Although sodium tetradecyl sulfate is unlikely to adversely affect the breastfed infant, international guidelines recommend that breastfeeding be withheld for 2 days after sclerotherapy.[1]Drug LevelsMaternal Levels. Relevant published information was not found as of the revision

Sodium Tetradecyl Sulfate: A Review of Clinical Uses. Sodium tetradecyl sulfate (STS) is Food and Drug Administration approved for treatment of varicose veins, but numerous other off-label applications have been reported. To describe the clinical uses of STS, as well as efficacy and adverse effects. Review of studies searchable on PubMed from 1938 to 2016 describing clinical uses of STS to determine efficacy and adverse effects associated with various applications. Sodium tetradecyl sulfate has shown efficacy in the treatment of varicose veins, telangiectasias, hemangioma, pyogenic granuloma, cherry angioma, Kaposi sarcoma, lymphangioma circumscriptum, digital mucous cyst, ganglion cyst, glomangioma, angiokeratoma of Fordyce, pseudocyst of the auricle, and verruca. Commonly reported side

Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins A 40-year-old woman with a history of alopecia areata related to stress or hormonal changes was treated for bilateral primary symptomatic varicose veins (CEAP clinical score C2S) of pelvic origin, using a staged procedure. Her first procedure entailed pelvic vein embolisation of three pelvic veins using 14 coils and including foam sclerotherapy of the tributaries, using 3% sodium tetradecyl sulphate. Following this procedure, she had an exacerbation of alopecia areata with some moderate shedding of hair. Subsequently, she underwent endovenous laser ablation under local anaesthetic without incident. Seven months after the pelvic vein embolisation, she underwent foam

Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations. To evaluate clinical outcomes and their predictors in patients with venous malformation (VM) treated with foam sodium tetradecyl sulfate (STS) sclerotherapy. We retrospectively evaluated clinical outcomes of foam STS sclerotherapy in 86 patients with 91 VMs to assess

Utility of sodium tetradecyl sulfate sclerotherapy from benign oral vascular lesion Hemangioma and vascular malformation are benign vascular lesions that often occur in cephalic and cervical region. Currently, surgical resection, laser therapy, angiographic embolization, use of steroids, and sclerotherapy are used as treatments. This study reports three cases of benign vascular lesions that are remarkably treated by sodium tetradecyl sulfate (STS) injection, of which occurred in oral cavity and around the mouth. Three percent of STS was diluted with 0.9 % of normal saline, and it was injected to the lesion site at least once. The result of treatment was evaluated based on clinical findings. Surgical treatment of hemangioma and vascular malformation occurred in oral cavity is not normally used

Efficacy and Safety of Balloon-Occluded Retrograde Transvenous Obliteration with Sodium Tetradecyl Sulfate Liquid Sclerotherapy To evaluate the efficacy and safety of balloon-occluded retrograde transvenous obliteration (BRTO) with sodium tetradecyl sulfate (STS) liquid sclerotherapy of gastric varices. Between February 2012 and August 2014, STS liquid sclerotherapy was performed in 17

Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations. Lymphatic malformations are congenital vascular anomalies that occur from abnormal development of the lymphatic channels. Studies have shown that sclerotherapy can be a reliable alternative to surgery. The purpose of this retrospective study is to evaluate the safety

Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases Vascular malformations are the most common congenital and neonatal vascular anomalies in the head and neck region. The demand for simple and esthetic vascular malformation treatments have increased more recently. In this study, two patients that were diagnosed with venous malformations were treated with sodium tetradecyl sulfate as a sclerosing agent. Recurrence was not found one year after the surgery. This article gives a brief case report of sclerotherapy as an effective approach to treat vascular malformations in the oral cavity.

Neuropathy after Sodium Tetradecyl Sulfate Sclerotherapy of Venous Malformations in Children. To estimate the risk of nerve injuries and assess outcomes after sodium tetradecyl sulfate (STS) sclerotherapy of venous malformations (VMs) in children. Sclerotherapy is the treatment of choice for most VMs, but all sclerotherapy agents are associated with the risk of complications. Neuropathy

Comparison of sonographically guided percutaneous sodium tetradecyl sulfate injection with ethanol injection in the treatment of benign nonfunctioning thyroid nodules. To compare the efficacy of percutaneous sodium tetradecyl sulfate (STS) injection with ethanol injection in the treatment of benign nonfunctioning thyroid nodules. This prospective study included 47 patients with 50 benign thyroid

Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions. Comparison of the efficacy of bleomycin over sodium tetradecyl sulfate (STS) when given intralesionally in the treatment of oral and maxillofacial venous malformation. 16 patients with venous malformation in craniofacial

Is there any evidence on the clinical and cost effectiveness of injection snoreplasty (sotradecol or sodium tetradecyl sulphate)? A 2009 Health Technology Assessment (HTA) examined surgical procedures and non-surgical devices for the management of non-apnoeic snoring: a systematic review of clinical effects and associated treatment costs (1). This discusses injection snoreplasty and reports of 2.0 ml of 1% sodium tetradecyl sulphate (10 mg/ml). For repeat procedures 3% Sotradecol (Bioniche Pharma; 30 mg/ml) was generally used and the site of injection modified to include the lateral areas of the soft palate as well as those not adequately stiffened by the previous procedure. Treatment sessions were performed 6–8 weeks apart, with a mean of 1.8 sessions per patient (range 1–4

Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children. Venous vascular malformations in the head and neck region present a difficult management challenge. We describe our experience of using sodium tetradecyl sulphate injection sclerotherapy to treat children presenting with venous malformations of the oral and pharyngeal region , tonsillar fossae, parapharyngeal space and soft palate. All patients were treated with 3% sodium tetradecyl sulphate (STS) foam injected trans-orally or percutaneously under ultrasound or fluoroscopic guidance. The lesions had a mean volume of 4 ml (range 2-14 ml). An average of 3 treatments was required (range 1-9). In 4 patients a single treatment was sufficient. For those patients requiring multiple

of the hemorrhoidal tissue with scarring and subsequent fixation of mucosa to submucosa. A 5% phenol solution in almond or vegetable oil is the most commonly used sclerosant and has been used for decades. Alternatives may include sodium tetradecyl sulfate, polidocanol foam, and aluminum potassium sulfate and tannic acid. A 2017 systematic review of 5 RCTs (n = 412) evaluating injection sclerotherapy described

are sodium tetradecyl sulfate and polidocanol. In high-flow pelvic varicoceles, there is a small risk of systemic dispersion of the sclerosant. In order to optimize the quantity and efficacy of the sclerosant, stop-flow foam sclerotherapy techniques have been described. This technique involves the use of balloon occlusion of high-outflow collaterals to achieve the complete filling of pelvic varices and exclusion of collaterals, thereby embolizing the entire length of incompetent vessels, including tributaries [57]. In a retrospective study of 26 patients involving the use of 3% sodium tetradecyl sulfate foam, significant improvement in symptoms was observed at 1, 3, 6, and 12 months. Of note, all patients had colic-like pain that spontaneously resolved after

wire with J-tip and microwiresEmbolic materials: polidocanol, sodium tetradecyl sulphate (STS), n-butyl cyanoacrylate (NBCA), coils and plugsAvailability of microcathetersTechniqueFemoral, jugular or brachial venous access is obtained, ideally with ultrasound guidance, and a 10 cm 4–6 Fr sheath is placed. Transfemoral approach has the advantage of avoiding a sensitive area in the neck, but it carries order to reduce radiation dose, the entire procedure may be performed under fluoroscopic guidance, without using digital subtraction angiography (DSA) [37].Embolic MaterialsCommonly used embolic agents are: sclerosants (including polidocanol–aetoxisclerol 2% or 3%, and sodium tetradecyl sulphate—STS); mechanical agents (coils and plugs); and tissue adhesives (cyanoacrylates). Sometimes a combination